Approved GLP-RAs In 2005, Exendin-4 (Exenatide/ BYETTA), the world's first GLP-1RA, was approved by the FDA for the adjuvant treatment of type 2 diabetes with two injections per day (BID)
The Challenge of Improving R&D Returns Remains Front and Center Deloitte's latest analysis examines the growing pressure on pharmaceutical R&D productivity and the strategies companies are using to improve returns on innovation
These systems often use biocompatible polymers like polyvinylpyrrolidone (PVP), polyvinyl alcohol (PVA), sodium alginate, or gelatin, and may include functional components such as egg-derived proteins or silk fibroin to mimic biological properties and enhance mechanical strength and drug stability [40]
Medications GLP-1 Weight Loss Medication Options Learn about GLP-1 weight loss medication options, review our GLP-1 weight loss program, or visit our medication tips and resources
Animal Nutrition, 19 , 13-34